|
1
|
Surawicz TS, Davis F, Freels S, Laws ER Jr
and Menck HR: Brain tumor survival: results from the National
Cancer Data Base. J Neurooncol. 40:151–160. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Furnari FB, Fenton T, Bachoo RM, et al:
Malignant astrocytic glioma: genetics, biology, and paths to
treatment. Genes Dev. 21:2683–2710. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Xu X, Xi L, Zeng J and Yao Q: A functional
+61G/A polymorphism in epidermal growth factor is associated with
glioma risk among Asians. PLoS One. 7:e414702012.
|
|
4
|
Lu J, Getz G, Miska EA, et al: MicroRNA
expression profiles classify human cancers. Nature. 435:834–838.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Dong H, Siu H, Luo L, Fang X, Jin L and
Xiong M: Investigation gene and microRNA expression in
glioblastoma. BMC Genomics. 11(Suppl 3): S162010. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Chen CZ: MicroRNAs as oncogenes and tumor
suppressors. N Engl J Med. 353:1768–1771. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Calin GA and Croce CM: MicroRNA signatures
in human cancers. Nat Rev Cancer. 6:857–866. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Bushati N and Cohen SM: microRNA
functions. Annu Rev Cell Dev Biol. 23:175–205. 2007. View Article : Google Scholar
|
|
9
|
Bartel DP: MicroRNAs: target recognition
and regulatory functions. Cell. 136:215–233. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Wang D, Qiu C, Zhang H, Wang J, Cui Q and
Yin Y: Human microRNA oncogenes and tumor suppressors show
significantly different biological patterns: from functions to
targets. PLoS One. 5:e130672010. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Chhabra R, Dubey R and Saini N:
Cooperative and individualistic functions of the microRNAs in the
miR-23a∼27a∼24-2 cluster and its implication in human diseases. Mol
Cancer. 9:2322010.PubMed/NCBI
|
|
12
|
Lal A, Navarro F, Maher CA, et al: miR-24
inhibits cell proliferation by targeting E2F2, MYC, and other
cell-cycle genes via binding to ‘seedless’ 3′UTR microRNA
recognition elements. Mol Cell. 35:610–625. 2009.PubMed/NCBI
|
|
13
|
Lal LS, Miller LA, Arbuckle R, et al:
Disparities in outpatient antidepressant prescribing patterns and
determinants of resource utilization at a tertiary care cancer
center. J Support Oncol. 7:237–244. 2009.PubMed/NCBI
|
|
14
|
Jones KJ, Skinner A, Xu L, Sun J and
Mueller K: The AHRQ Hospital Survey on Patient Safety Culture: A
Tool to Plan and Evaluate Patient Safety Programs. Advances in
Patient Safety: New Directions and Alternative Approaches.
Henriksen K, Battles JB, Keyes MA and Grady ML: Vol 2. Culture and
Redesign. Agency for Healthcare Research and Quality; Rockville,
MD: 2008, PubMed/NCBI
|
|
15
|
Fukuda Y, Kawasaki H and Taira K:
Exploration of human miRNA target genes in neuronal
differentiation. Nucleic Acids Symp Ser (Oxf). 341–342. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Qin W, Shi Y, Zhao B, et al: miR-24
regulates apoptosis by targeting the open reading frame (ORF)
region of FAF1 in cancer cells. PLoS One. 5:e94292010. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Cheng AM, Byrom MW, Shelton J and Ford LP:
Antisense inhibition of human miRNAs and indications for an
involvement of miRNA in cell growth and apoptosis. Nucleic Acids
Res. 33:1290–1297. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Feng J, Iwama A, Satake M and Kohu K:
MicroRNA-27 enhances differentiation of myeloblasts into
granulocytes by post-transcriptionally downregulating Runx1. Br J
Haematol. 145:412–423. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
McDaneld TG, Smith TP, Doumit ME, et al:
MicroRNA transcriptome profiles during swine skeletal muscle
development. BMC Genomics. 10:772009. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Wang T and Xu Z: miR-27 promotes
osteoblast differentiation by modulating Wnt signaling. Biochem
Biophys Res Commun. 402:186–189. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Mertens-Talcott SU, Chintharlapalli S, Li
X and Safe S: The oncogenic microRNA-27a targets genes that
regulate specificity protein transcription factors and the G2-M
checkpoint in MDA-MB-231 breast cancer cells. Cancer Res.
67:11001–11011. 2007. View Article : Google Scholar
|
|
22
|
Ji J, Zhang J, Huang G, Qian J, Wang X and
Mei S: Over-expressed microRNA-27a and 27b influence fat
accumulation and cell proliferation during rat hepatic stellate
cell activation. FEBS Lett. 583:759–766. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Lee Y, Kim M, Han J, et al: MicroRNA genes
are transcribed by RNA polymerase II. EMBO J. 23:4051–4060. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Sun F, Wang J, Pan Q, et al:
Characterization of function and regulation of miR-24-1 and miR-31.
Biochem Biophys Res Commun. 380:660–665. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Ciafrè SA, Galardi S, Mangiola A, et al:
Extensive modulation of a set of microRNAs in primary glioblastoma.
Biochem Biophys Res Commun. 334:1351–1358. 2005.PubMed/NCBI
|
|
26
|
Landgraf P, Rusu M, Sheridan R, et al: A
mammalian microRNA expression atlas based on small RNA library
sequencing. Cell. 129:1401–1414. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Henriksson M and Lüscher B: Proteins of
the Myc network: essential regulators of cell growth and
differentiation. Adv Cancer Res. 68:109–182. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Schreiber-Agus N and DePinho RA:
Repression by the Mad(Mxi1)-Sin3 complex. Bioessays. 20:808–818.
1998. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Fujimoto M, Fults DW, Thomas GA, et al:
Loss of heterozygosity on chromosome 10 in human glioblastoma
multiforme. Genomics. 4:210–214. 1989. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Rasheed BK, Fuller GN, Friedman AH, Bigner
DD and Bigner SH: Loss of heterozygosity for 10q loci in human
gliomas. Genes Chromosomes Cancer. 5:75–82. 1992. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Ransom DT, Ritland SR, Moertel CA, et al:
Correlation of cytogenetic analysis and loss of heterozygosity
studies in human diffuse astrocytomas and mixed oligo-astrocytomas.
Genes Chromosomes Cancer. 5:357–374. 1992. View Article : Google Scholar
|
|
32
|
Carter BS, Ewing CM, Ward WS, et al:
Allelic loss of chromosomes 16q and 10q in human prostate cancer.
Proc Natl Acad Sci USA. 87:8751–8755. 1990. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Lundgren R, Mandahl N, Heim S, Limon J,
Henrikson H and Mitelman F: Cytogenetic analysis of 57 primary
prostatic adenocarcinomas. Genes Chromosomes Cancer. 4:16–24. 1992.
View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Ko JY, Yoo KH, Lee HW and Park JH: Mxi1
regulates cell proliferation through insulin-like growth factor
binding protein-3. Biochem Biophys Res Commun. 415:36–41. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Tsao CC, Teh BT, Jonasch E, et al:
Inhibition of Mxi1 suppresses HIF-2alpha-dependent renal cancer
tumorigenesis. Cancer Biol Ther. 7:1619–1627. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Ebert MS, Neilson JR and Sharp PA:
MicroRNA sponges: competitive inhibitors of small RNAs in mammalian
cells. Nat Methods. 4:721–726. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Catuogno S, Esposito CL, Quintavalle C,
Condorelli G, de Franciscis V and Cerchia L: Nucleic acids in human
glioma treatment: innovative approaches and recent results. J
Signal Transduct. 2012:7351352012. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Esquela-Kerscher A and Slack FJ: Oncomirs
- microRNAs with a role in cancer. Nat Rev Cancer. 6:259–269. 2006.
View Article : Google Scholar
|
|
39
|
Feng SY, Dong CG, Wu WK, Wang XJ, Qiao J
and Shao JF: Lentiviral expression of anti-microRNAs targeting
miR-27a inhibits proliferation and invasiveness of U87 glioma
cells. Mol Med Rep. 6:275–281. 2012.PubMed/NCBI
|
|
40
|
Guttilla IK and White BA: Coordinate
regulation of FOXO1 by miR-27a, miR-96, and miR-182 in breast
cancer cells. J Biol Chem. 284:23204–23216. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Zhu H, Wu H, Liu X, et al: Role of
MicroRNA miR-27a and miR-451 in the regulation of
MDR1/P-glycoprotein expression in human cancer cells. Biochem
Pharmacol. 76:582–588. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Wechsler DS, Shelly CA, Petroff CA and
Dang CV: MXI1, a putative tumor suppressor gene, suppresses growth
of human glioblastoma cells. Cancer Res. 57:4905–4912.
1997.PubMed/NCBI
|
|
43
|
Schreiber-Agus N, Meng Y, Hoang T, et al:
Role of Mxi1 in ageing organ systems and the regulation of normal
and neoplastic growth. Nature. 393:483–487. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Kuczyk MA, Serth J, Bokemeyer C, et al:
The MXI1 tumor suppressor gene is not mutated in primary prostate
cancer. Oncol Rep. 5:213–216. 1998.PubMed/NCBI
|
|
45
|
Mauleon I, Lombard MN, Muñoz-Alonso MJ,
Cañelles M and Leon J: Kinetics of myc-max-mad gene expression
during hepatocyte proliferation in vivo: Differential regulation of
mad family and stress-mediated induction of c-myc. Mol Carcinog.
39:85–90. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Swartling FJ: Myc proteins in brain tumor
development and maintenance. Ups J Med Sci. 117:122–131. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Gustafson WC and Weiss WA: Myc proteins as
therapeutic targets. Oncogene. 29:1249–1259. 2010. View Article : Google Scholar : PubMed/NCBI
|
